Shandong Lukang Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Shandong Lukang Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Shandong Lukang Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Net cash flows from investing activities332,176,9800.05894162015-06-30historic
Other non-current liabilities71,686,6570.01272372015-06-30historic
Cash from other investing activities399,947,1360.07097372015-06-30historic
Long term accounts payable270,444,9720.04799692015-06-30historic
Fair value change gain2,265,6604.0E-4812015-06-30historic
Other current liabilities35,530,6590.00631522015-06-30historic
Refunds of taxes20,987,9260.003721682015-06-30historic
Payroll payable47,727,9860.008471822015-06-30historic
Interests payable15,813,7030.002811882015-06-30historic
Disposal of fixed assets and others1,603,8402.8E-41962015-06-30historic
Notes receivable171,518,2350.030442002015-06-30historic
Selling expenses95,517,4110.016952232015-06-30historic
Investment income from associate and joint venture1,853,1763.3E-42242015-06-30historic
Fixed assets1,582,265,2520.280772252015-06-30historic
Capital reserve1,079,879,3710.191622612015-06-30historic
Long term borrowings314,943,3330.055892632015-06-30historic
Cash paid for other investing activities4,211,2007.5E-42642015-06-30historic
Long term equity investment120,602,3290.02142712015-06-30historic
Intangible assets212,034,6810.037632962015-06-30historic
Accounts payable492,315,1980.087363032015-06-30historic
Financial expenses33,352,9400.005923062015-06-30historic
Other receivables62,675,8900.011123332015-06-30historic
Total non-current assets2,218,818,3300.393723352015-06-30historic
Total cost of goods sold1,153,429,8180.204673572015-06-30historic
Cash outflows from operating activities1,306,933,9370.231913652015-06-30historic
Cash inflows from operating activities1,307,209,9090.231963732015-06-30historic
Minority interest96,233,9620.017083792015-06-30historic
Revenue1,149,152,4770.203913812015-06-30historic
Inventories530,278,8750.09414112015-06-30historic
Total liabilities2,080,301,9960.369144152015-06-30historic
Cash paid for other financing activities6,588,3000.001174402015-06-30historic
Cash paid for taxes67,581,1350.011994442015-06-30historic
Total liabilities and equity3,992,027,1930.708384572015-06-30historic
Purchases of fixed assets and others66,403,6000.011784592015-06-30historic
Comprehensive income attributable to minority shareholders824,9761.5E-44652015-06-30historic
Minority interests gain824,9761.5E-44762015-06-30historic
Other current assets48,433,3330.008594982015-06-30historic
Prepayment64,180,2000.011395152015-06-30historic
Other payables69,917,6330.012415242015-06-30historic
Proceeds from sell of investment679,7441.2E-45442015-06-30historic
Net cash and cash equivalents ending balance367,251,5760.065175742015-06-30historic
Non-operating loss475,4798.0E-56842015-06-30historic
Cash inflows from financing activities259,558,1250.046067232015-06-30historic
Cash paid for dividends, profits or interests20,850,5570.00378552015-06-30historic
Short term borrowings59,870,1200.010628942015-06-30historic
Deferred tax assets4,920,4428.7E-49782015-06-30historic
Net change in cash-82,801,424-0.0146910052015-06-30historic
Total comprehensive income4,387,6657.8E-410882015-06-30historic
Operating profit1,082,2301.9E-410912015-06-30historic
Total profit5,915,5390.0010511062015-06-30historic
Net income1,395,3452.5E-411342015-06-30historic
Diluted eps00.012912015-06-30historic
Net cashflow from financing activities-418,619,919-0.0742812972015-06-30historic